Association of high anti-donor alloreactivity and low frequency of FoxP3-expressing cells prior to kidney transplantation with acute graft rejection

Clinical Transplantation

Volumn 25, Issue 6, 2011, Pages 905-914

  Vondran, Florian W R ^a   Timrott, Kai ^a   Tross, Janice ^a   Kollrich, Sonja ^a   Gwinner, Wilfried ^a   Lehner, Frank ^a   Klempnauer, Juergen ^a   Becker, Thomas ^a   Schwinzer, Reinhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acute rejection; Alloreactivity; Anti donor; Kidney transplantation; Mixed lymphocyte culture; Regulatory T cells

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ADULT; AGED; ALLOIMMUNITY; ANTIGEN EXPRESSION; ARTICLE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MIXED LYMPHOCYTE CULTURE; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LEUKOCYTES, MONONUCLEAR; LIVING DONORS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 83455195783     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01354.x     Document Type: Article

References (43)

1. Hawksworth JS, Leeser D, Jindal RM, Falta E, Tadaki D, Elster EA. New directions for induction immunosuppression strategy in solid organ transplantation. Am J Surg 2009: 197: 515.
2. Yabu JM, Vincenti F. Kidney transplantation: the ideal immunosuppression regimen. Adv Chronic Kidney Dis 2009: 16: 226.
3. Geissler EK, Schlitt HJ. Immunosuppression for liver transplantation. Gut 2009: 58: 452.
4. Krieger NR, Becker BN, Heisey DM et al. Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation 2003: 75: 1677.
5. Li C, Yang CW. The pathogenesis and treatment of chronic allograft nephropathy. Nat Rev Nephrol 2009: 5: 513.
6. Opelz G, Dohler B. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation 2007: 84: 137.
7. Lee PC, Ozawa M. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Transplant Proc 2009: 41: 95.
8. Vaidya S. Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches. Transplantation 2008: 85: 1046.
9. Game DS, Lechler RI. Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 2002: 10: 101.
10. Harmon WE, Parkman R, Lavin PT et al. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation. J Immunol 1982: 129: 1573.
11. Van Der Mast BJ, Van Besouw NM, De Kuiper P et al. Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression. Transplantation 2001: 72: 873.
12. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005: 6: 345.
13. Jiang S, Lechler RI, He XS, Huang JF. Regulatory T cells and transplantation tolerance. Hum Immunol 2006: 67: 765.
14. Seddiki N, Santner-Nanan B, Martinson J et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006: 203: 1693.
15. Sojka DK, Huang YH, Fowell DJ. Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target. Immunology 2008: 124: 13.
16. Lopez-Hoyos M, Segundo DS, Fernandez-Fresnedo G, Marin MJ, Gonzalez-Martin V, Arias M. Regulatory T cells in renal transplantation and modulation by immunosuppression. Transplantation 2009: 88: S31.
17. Alvarez CM, Opelz G, Garcia LF, Susal C. Expression of regulatory T-cell-related molecule genes and clinical outcome in kidney transplant recipients. Transplantation 2009: 87: 857.
18. Bestard O, Cruzado JM, Mestre M et al. Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol 2007: 179: 4901.
19. Stenard F, Nguyen C, Cox K et al. Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients. Pediatr Transplant 2009: 13: 70.
20. Louis S, Braudeau C, Giral M et al. Contrasting CD25hiCD4+ T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006: 81: 398.
21. Bestard O, Cruzado JM, Rama I et al. Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 2008: 19: 2020.
22. Karczewski M, Karczewski J, Kostrzewa A, Wiktorowicz K, Glyda M. The role of Foxp3+ regulatory T cells in kidney transplantation. Transplant Proc 2009: 41: 1527.
23. Segundo DS, Fernandez-Fresnedo G, Ruiz JC et al. Two-year follow-up of a prospective study of circulating regulatory T cells in renal transplant patients. Clin Transplant 2010: 24: 386.
24. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008: 8: 753.
25. Vondran FW, Timrott K, Tross J et al. Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation. Transpl Int 2010: 23: 514.
26. Meier-Kriesche HU, Ojo AO, Hanson JA et al. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation 2000: 70: 1098.
27. Tejani A, Ho PL, Emmett L, Stablein DM. Reduction in acute rejections decreases chronic rejection graft failure in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Transplant 2002: 2: 142.
28. Tanaka Y, Ohdan H, Onoe T et al. Low incidence of acute rejection after living-donor liver transplantation: immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique. Transplantation 2005: 79: 1262.
29. Bohmig GA, Saemann MD, Bergmann M et al. Long-term evaluation of proliferative donor antigen-specific reactivity in cadaveric kidney transplant recipients. Transpl Int 2000: 13: 187.
30. Cochrum KC, Salvatierra O, Belzer FO. Correlation between MLC stimulation and graft survival in living related and cadaver transplants. Ann Surg 1974: 180: 617.
31. Creemers P, Du Toit E, Cassidy MJ, Kahn D. Sequential mixed lymphocyte culture after kidney transplantation: induction of tolerance or sensitization. Nephron 1997: 75: 166.
32. Heeger PS, Greenspan NS, Kuhlenschmidt S et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999: 163: 2267.
33. Nickel P, Presber F, Bold G et al. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12months in renal-transplant recipients. Transplantation 2004: 78: 1640.
34. Ford ML, Kirk AD, Larsen CP. Donor-reactive T-cell stimulation history and precursor frequency: barriers to tolerance induction. Transplantation 2009: 87: S69.
35. Brehm MA, Markees TG, Daniels KA, Greiner DL, Rossini AA, Welsh RM. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J Immunol 2003: 170: 4077.
36. Page AJ, Ford ML, Kirk AD. Memory T-cell-specific therapeutics in organ transplantation. Curr Opin Organ Transplant 2009: 14: 643.
37. Schwinzer R, Siefken R. CD45RA+ and CD45RO+ T cells differ in susceptibility to cyclosporin A mediated inhibition of interleukin-2 production. Transpl Immunol 1996: 4: 61.
38. Wissing KM, Fomegne G, Broeders N et al. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies. Transplantation 2008: 85: 411.
39. Takemoto S, Port FK, Claas FH, Duquesnoy RJ. HLA matching for kidney transplantation. Hum Immunol 2004: 65: 1489.
40. Demirkiran A, Kok A, Kwekkeboom J et al. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl 2006: 12: 277.
41. Thornton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000: 164: 183.
42. Dijke IE, Korevaar SS, Caliskan K et al. Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejection. Transplantation 2009: 87: 1191.
43. Codarri L, Vallotton L, Ciuffreda D et al. Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients. J Exp Med 2007: 204: 1533.